Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Novo Nordisk and Eli Lilly Could Have a Big Rival in the GLP-1 Market in a Few Years
August 18, 2024
Tickers
LLY
NVO
RHHBY
Tags
RHHBY
Market News
Recent Press Releases
From
Motley Fool
Roche Misses Out On Weight-Loss Blockbuster Drug, Now Playing Catch-Up In Booming Market
August 16, 2024
Tickers
LLY
NEWS
NVO
RHHBY
Tags
Market News
RHHBY
LLY
From
Benzinga
Why Is Small-Cap Tempest Therapeutics Stock Trading Higher On Thursday?
August 15, 2024
Tickers
NEWS
RHHBY
TPST
Tags
FDA
Small Cap
General
From
Benzinga
Prediction: This Company Will Disrupt Eli Lilly and Novo Nordisk in the Weight Loss Market (Hint: It's Not Pfizer)
August 15, 2024
Tickers
LLY
NVO
RHHBY
Tags
RHHBY
NVO
LLY
From
Motley Fool
Cancer-Focused Syros Pharmaceuticals Stops Mid-Stage Leukemia Combo Therapy Study, Cites Disappointing Unexpected Outcome
August 13, 2024
Tickers
ABBV
BMY
NEWS
RHHBY
Tags
Benzinga
Stories That Matter
Movers
From
Benzinga
Merck Stops Lung Cancer Study For Keytruda Combo Due To Ineffective Results, Side Effects
August 08, 2024
Tickers
MRK
NEWS
RHHBY
Tags
Large Cap
Briefs
News
From
Benzinga
Here's Why Eli Lilly Stock Dropped 12% Last Month
August 08, 2024
Tickers
AMGN
LLY
NVO
PFE
Tags
PFE
AMGN
LLY
From
Motley Fool
Roche Considers Selling Cancer Data Specialist Flatiron Health Business, Highlights Challenges With Start-Up Acquisitions
August 07, 2024
Tickers
C
GOOG
GOOGL
NEWS
Tags
Market News
M&A
RHHBY
From
Benzinga
Bristol Myers Squibb Terminates Cancer Drug Development Program With Agenus
August 05, 2024
Tickers
AGEN
BMY
MRK
NEWS
Tags
Health Care
Top Stories
News
From
Benzinga
Are Eli Lilly and Novo Nordisk Too Expensive For You? Here Are 4 Other Potential Weight Loss Stocks You May Want to Consider Right Now.
August 02, 2024
Tickers
ALT
LLY
NVO
PFE
Tags
Market News
ALT
RHHBY
From
Motley Fool
Weight Loss Drug Stocks Just Took a Hit. Should You Buy the Stock That Caused It?
July 29, 2024
Tickers
LLY
NVO
RHHBY
Tags
RHHBY
LLY
NVO
From
Motley Fool
Novo Nordisk's Stock Dips In Pre-Market Despite Winning UK's Approval Of Weight Loss Drug: What's Going On
July 24, 2024
Tickers
LLY
NEWS
NVO
PFE
Tags
Pre/Market Outlook
NVO
LLY
From
Benzinga
Look Out, Eli Lilly and Novo Nordisk: Could Roche Be the Obesity Drug Stock to Really Watch?
July 23, 2024
Tickers
LLY
NVO
RHHBY
Tags
NVO
LLY
Recent Press Releases
From
Motley Fool
Oral Weight Loss Drugs Vs. Injections - Pills Are Promising Yet Challenging Frontier
July 22, 2024
Tickers
LLY
NEWS
NVO
PFE
Tags
PFE
Briefs
Biotech
From
Benzinga
This Big Pharma Could Become a Leading Weight-Loss Stock. Should You Buy It?
July 22, 2024
Tickers
RHHBY
Tags
RHHBY
Recent Press Releases
Market News
From
Motley Fool
Better Dark Horse Weight Loss Drug Stock: Pfizer vs. Roche
July 22, 2024
Tickers
PFE
RHHBY
Tags
RHHBY
PFE
Recent Press Releases
From
Motley Fool
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
July 18, 2024
Tickers
AMGN
AZN
HRTS
LLY
Tags
Benzinga
Biotech
THNR
From
Benzinga
VIX Stages Double-Digit Spike As Risk Off Takes Over; Chipmakers Fail To Rebound, Weight Loss Giants Eli Lilly, Novo Tumble: What's Driving Markets Thursday?
July 18, 2024
Tickers
AA
ABT
ALK
BX
Tags
VIRT
DPZ
Market News
From
Benzinga
Why Roche Stock Just Popped, but Eli Lilly and Novo Nordisk Dropped
July 17, 2024
Tickers
LLY
NVO
RHHBY
Tags
NVO
LLY
Market News
From
Motley Fool
Pfizer And Roche Advance On Their Weight Loss Drug Journeys
July 17, 2024
Tickers
LLY
NEWS
NVO
PFE
Tags
General
RHHBY
Markets
From
Benzinga
Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics?
July 17, 2024
Tickers
GPCR
LLY
NEWS
NVO
Tags
News
Large Cap
LLY
From
Benzinga
Roche Highlights Encouraging Data From Newly-Acquired Second Weight Loss Drug Candidate In Early-Stage Study
July 17, 2024
Tickers
NEWS
RHHBY
Tags
Large Cap
News
Equities
From
Benzinga
3 Small-Cap Stocks With Explosive 2X Growth Potential
July 08, 2024
Tickers
AMGN
BAYRY
CHPT
EXAI
Tags
AMGN
NYSE:CHPT,NASDAQ:EXAI,NASDAQ:VRDN,OTCMKTS:RHHBY,OTCMKTS:BAYRY,NASDAQ:AMGN
Stocks to Buy
From
InvestorPlace
Roche's New Immunotherapy Fails To Show Benefit Over Merck's Blockbuster Keytruda In Lung Cancer Patients
July 05, 2024
Tickers
MRK
NEWS
RHHBY
Tags
Health Care
Top Stories
Large Cap
From
Benzinga
AbbVie/Genmab's Epkinly FDA Approval Is A Positive Step, Analyst Says Additional Expansion Opportunities Underway
June 27, 2024
Tickers
ABBV
BNTX
GMAB
JNJ
Tags
Biotech
Stories That Matter
Benzinga
From
Benzinga
Supreme Court Backs Pharmaceutical Giants in Iraq Terrorism Funding Case
June 24, 2024
Tickers
AZN
GEHC
JNJ
NEWS
Tags
Media
General
Legal
From
Benzinga
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
June 21, 2024
Tickers
AMGN
AZN
BMY
GILD
Tags
Media
General
Biotech
From
Benzinga
Sarepta Therapeutics (SRPT) Stock Surges 30% on Giant FDA Boost
June 21, 2024
Tickers
RHHBY
SRPT
Tags
Market News
SRPT
Today's Market
From
InvestorPlace
FDA Approves Expanded Use For Sarepta's Rare Muscular Dystrophy Gene Therapy
June 21, 2024
Tickers
NEWS
PFE
RGNX
RHHBY
Tags
Benzinga
Stories That Matter
Movers
From
Benzinga
Goldman Sachs Optimistic About Regenxbio's Gene Therapy Pipeline, Sees Over 160% Upside
June 07, 2024
Tickers
ABBV
FDMT
NEWS
REGN
Tags
Benzinga
Stories That Matter
Movers
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.